Seeing Is Believing
Currently out of the existing stock ratings of David Rescott, 111 are a BUY (88.1%), 15 are a HOLD (11.9%).
Analyst David Rescott, currently employed at BAIRD, carries an average stock price target met ratio of 57.19% that have a potential upside of 21.74% achieved within 131 days. Previously, David Rescott worked at TRUIST.
David Rescott’s has documented 259 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BSX, Boston Scientific Corp at 30-Sep-2025.
Analyst best performing recommendations are on EW (EDWARDS LIFESCIENCES CORP).
The best stock recommendation documented was for IRTC (IRHYTHM TECHNOLOGIES) at 10/31/2024. The price target of $85 was fulfilled within 5 days with a profit of $12.56 (17.34%) receiving and performance score of 34.68.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell
$75
$-22.7 (-23.23%)
1 years 7 months 18 days ago
(20-Feb-2024)
4/5 (80%)
$-6.12 (-7.54%)
545
Hold
$82
$-3.06 (-3.60%)
$89
1 years 10 months 17 days ago
(22-Nov-2023)
2/9 (22.22%)
$4.28 (5.51%)
14
Buy
$95
$-2.7 (-2.76%)
$90
2 years 1 months 17 days ago
(21-Aug-2023)
5/12 (41.67%)
$17.26 (22.20%)
658
Hold
$87
$-10.7 (-10.95%)
$80
2 years 7 months 17 days ago
(21-Feb-2023)
5/8 (62.5%)
$9.27 (11.93%)
453
Buy
$95
$-2.7 (-2.76%)
$100
2 years 8 months 15 days ago
(23-Jan-2023)
1/2 (50%)
$21.19 (28.71%)
974
Which stock is David Rescott is most bullish on?
Which stock is David Rescott is most reserved on?
What Year was the first public recommendation made by David Rescott?